The drug regulator has approved the AstraZeneca COVID-19 vaccine for use in Australia, giving the green light for injections for millions of Australians from next week.
Monday’s provisional approval for adults over 18 will see the Oxford University-developed drug administered in two doses, four to 12 weeks apart. The drug is recommended for adults over 65, with high efficacy in preventing serious illness and death.
Loading...
Tom McIlroy is the Financial Review’s Canberra bureau chief based in the press gallery at Parliament House. He was previously the AFR’s political correspondent. Connect with Tom on Twitter. Email Tom at thomas.mcilroy@afr.com
